S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Turnstone Biologics Corporation (TSBX)
Turnstone Biologics Corporation (TSBX) News

TSBX

Turnstone Biologics (TSBX)

Turnstone Biologics Corporation

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TSBX

1

Date	Time	Source	Headline	Symbol	Company
06/05/2024	4:00PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TSBX	Turnstone Biologics Corporation
05/31/2024	3:23PM	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:TSBX	Turnstone Biologics Corporation
05/13/2024	4:15PM	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:TSBX	Turnstone Biologics Corporation
05/13/2024	4:05PM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TSBX	Turnstone Biologics Corporation
05/13/2024	4:03PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TSBX	Turnstone Biologics Corporation
05/13/2024	4:01PM	GlobeNewswire Inc.	Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights	NASDAQ:TSBX	Turnstone Biologics Corporation
05/08/2024	8:00AM	GlobeNewswire Inc.	Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference	NASDAQ:TSBX	Turnstone Biologics Corporation
04/16/2024	8:00AM	GlobeNewswire Inc.	Turnstone Biologics Appoints William Waddill to its Board of Directors	NASDAQ:TSBX	Turnstone Biologics Corporation
03/21/2024	4:06PM	GlobeNewswire Inc.	Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights	NASDAQ:TSBX	Turnstone Biologics Corporation
03/05/2024	7:30AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TSBX	Turnstone Biologics Corporation
02/21/2024	5:00AM	GlobeNewswire Inc.	Turnstone Biologics to Participate in Upcoming Investor Conferences	NASDAQ:TSBX	Turnstone Biologics Corporation
02/20/2024	4:00PM	GlobeNewswire Inc.	Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.	NASDAQ:TSBX	Turnstone Biologics Corporation
11/27/2023	5:00AM	GlobeNewswire Inc.	Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference	NASDAQ:TSBX	Turnstone Biologics Corporation
11/09/2023	8:49PM	GlobeNewswire Inc.	Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights	NASDAQ:TSBX	Turnstone Biologics Corporation
11/03/2023	5:00AM	GlobeNewswire Inc.	Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting	NASDAQ:TSBX	Turnstone Biologics Corporation
10/30/2023	5:00AM	GlobeNewswire Inc.	Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber	NASDAQ:TSBX	Turnstone Biologics Corporation
10/17/2023	5:42PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TSBX	Turnstone Biologics Corporation
10/17/2023	5:41PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TSBX	Turnstone Biologics Corporation
10/17/2023	5:38PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TSBX	Turnstone Biologics Corporation
10/17/2023	5:37PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TSBX	Turnstone Biologics Corporation
10/17/2023	5:36PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TSBX	Turnstone Biologics Corporation
10/17/2023	5:34PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TSBX	Turnstone Biologics Corporation
09/28/2023	5:00AM	GlobeNewswire Inc.	Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting	NASDAQ:TSBX	Turnstone Biologics Corporation
09/01/2023	4:57PM	GlobeNewswire Inc.	Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update	NASDAQ:TSBX	Turnstone Biologics Corporation
09/01/2023	3:39PM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TSBX	Turnstone Biologics Corporation
07/21/2023	1:15AM	GlobeNewswire Inc.	Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering	NASDAQ:TSBX	Turnstone Biologics Corporation

Showing the most relevant articles for your search:NASDAQ:TSBX

1

New Momentum (PK)

Cann American (CE)

Elite Pharmaceuticals (QB)

RespireRx Pharmaceuticals (PK)

Therapeutic Solutions (PK)

Rennova Health (PK)

Gold and GemStone Mining (PK)

Asia Broadband (PK)

Progressive Care (QB)

Ubiquitech Software (PK)

Bell Buckle (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions